title: Exercise training for patients with cardiovascular disease.
abstract: This review surveys effort training, a validated and recommended therapy, in patients with atheromatous cardiovascular disease. This true therapy reduces mortality by 25-35%, reduces clinical manifestations and complications (rhythm problems, thrombosis) and improves physical capacity, reintegration and quality of life. The effects are essentially linked to improved metabolic performance of muscles and reduced endothelial dysfunction, insulin resistance and neurohormonal abnormalities. Training also has an impact on the evolution of major risk factors, especially diabetes and arterial hypertension. The risks are limited as long as the contraindications are respected and the programmes supervised. The indications (stable angina, chronic heart failure, peripheral arterial disease) should be described more precisely by taking into account functional criteria: physical deconditioning, exclusion, compliance, mood swings, and seriousness of risk factors. The training programme should be tailor made and based on evaluation of the patient's adaptation to effort, in terms of frequency, intensity and duration of the exercises. Various types of exercise include overall or segmental physical training; concentric, eccentric, even isokinetic muscle contraction exercises; and proprioceptive rehabilitation. However, knowledge is lacking about the molecular mechanisms of the effects of training, the most effective intensity of effort, and strategies to develop physical activity in this ever-growing population for both primary and secondary prevention.
authors: Pôle rééducation-réadaptation, Inserm U887, CHU de Dijon, 23, rue Gaffarel, 21079 Dijon cedex, France. jean-marie.casillas@chu-dijon.fr
authors: J M
authors: JM
authors: Casillas
authors: V
authors: V
authors: Gremeaux
authors: S
authors: S
authors: Damak
authors: A
authors: A
authors: Feki
authors: D
authors: D
authors: Pérennou
mesh_terms: D002318:Cardiovascular Diseases / Q000628:therapy*; D000075202:Contraindications; D005081:Exercise Therapy / Q000009:adverse effects / Q000379:methods; D006801:Humans; D012307:Risk Factors